Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sticky ultrasound patch could keep tabs on unborn babies

NCT ID NCT07676474

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study tests a wireless, sticky ultrasound patch that sticks to a pregnant woman's belly to monitor her baby's health. The patch records images and data for 10 to 30 minutes. Researchers want to see if the patch is comfortable, stays in place, and provides good-quality images. The study involves 50 pregnant women with a single baby, between 20 and 39 weeks of pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wireless bioadhesive ultrasound device
What this could lead to
If successful, this could lead to a comfortable, wearable way to continuously monitor fetal health without bulky equipment.
What could go wrong
This is a small, early feasibility study with only 50 participants. The device may not provide clear enough images or may cause skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population is limited to persons with a single pregnancy who are receiving a clinically-ordered MRI at Boston Children's Hospital as part of their clinical care.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Pregnant individual 18 years or older 2. Singleton uterine pregnancy 3. Gestational age 20 to 39 gestational weeks 4. Able to provide written informed consent 5. Willing to go an single visit lasting 45 minutes - 1 hour including device placement, monitoring and removal 6. Willing to permit placement of the wireless bioadhesive ultrasound device on their abdomen for approximately 10-30 minutes Exclusion Criteria: 1. Multiple gestation 2. Maternal abdominal skin condition at the potential site of attachment, such as rash, open wound, etc., preventing placement 3. Known allergy or hypersensitivity to adhesive material or hydrogel products 4. Need for urgent clinical management/triage 5. BMI \> 35, as the signal quality could be impacted by BMI and not the device specifically

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnant woman with single pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States